Showing 121 - 130 of 212
Persistent link: https://www.econbiz.de/10003183235
Dramatic increases in health expenditures have led to a substantial number of regulatory interventions in the markets for devices over the last years. However, little attention has been paid thus far to the regulation of medical devices and its effects. This article explore the policies pursued...
Persistent link: https://www.econbiz.de/10013070164
What are skill-mix innovations and why are they relevant? This systemic analysis of health workforce skill-mix innovations provides an overview of the evidence and lessons for implementation across multiple countries. The authors focus on six core segments of health systems: health promotion and...
Persistent link: https://www.econbiz.de/10013284728
The issue of defining health benefit catalogues has recently gained new importance in Germany as a result of the creation of the new Institute for Quality and Efficiency. The Institute was designed to support the Federal Joint Committee conducting effectiveness studies for benefit coverage...
Persistent link: https://www.econbiz.de/10013146562
Since their introduction in 1993, the structure of physician drug budgets in Germany has changed frequently. Although highly disputed, they have limited the pharmaceutical expenditure of the Statutory Health Insurance Scheme for nearly one decade. This raises the question of how these savings...
Persistent link: https://www.econbiz.de/10013146564
This review is one in a series of analytic efforts designed to inform the policy debate related to health financing. The authors review evidence on health financing arrangements in high income countries as well as reforms over the last 30 years and to identify key policy lessons from this...
Persistent link: https://www.econbiz.de/10012558292
<Emphasis Type="Bold">Background: The high number of patients with acute myocardial infarction (AMI) has facilitated greater research, resulting in the development of innovative medical devices. So far, results from economic evaluations that compared drug-eluting stents (DES) and bare-metal stents (BMS) have not...</emphasis>
Persistent link: https://www.econbiz.de/10011000748
Background:Background: The high number of patients with acute myocardial infarction (AMI) has facilitated greater research, resulting in the development of innovative medical devices. So far, results from economic evaluations that compared drug-eluting stents (DES) and bare-metal stents (BMS)...
Persistent link: https://www.econbiz.de/10011005060
Persistent link: https://www.econbiz.de/10011005291
Persistent link: https://www.econbiz.de/10011005303